Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014)
Clinical trial NCT02476890 · COMPLETED
Trial details
- NCT number
- NCT02476890
- Sponsor
- Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-28
- Primary completion
- 2016-10-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.